Kidney transplantation has been a part of the world medical scene for more than 45 years and simultaneous kidney-pancreas transplantation for more than 20 years. Improvements in medical techniques, immunosuppressive therapy, and expansion of patient eligibility have led to a population more in need of home health services than ever before. The home health needs of the population range from typical chronic health care needs to issues specifically associated with immunosuppression.
Auchincloss, H. , & Shaffer, D. (1999). Pancreas transplantation. In L. C. Ginns, A. B. Cosimi, & P. J. Morris (Eds.), Transplantation (pp. 395-421). Malden, MA: Blackwell Science.
2.
Bartucci, M. R. , Loughman, K. A., & Moir, E. J. (1992). Kidney-pancreas transplantation: A treatment option for ESRD and Type I diabetes. ANNA Journal, 19, 467-474.
3.
Bass, M. (1990). Infection in renal transplantation: The first six months. Critical Care Nursing Clinics of North America, 2, 133-138.
4.
Haggerty, L. M. , & Sigardson-Poor, K. M. (1990). Kidney transplantation. In K. M. Sigardson-Poor & L. M. Haggerty (Eds.), Nursing care of the transplant recipient (pp. 114-139). Philadelphia: Saunders.
5.
Limaye, A. P. , Corey, L., Koelle, D. M., David, C. L., & Boeckh, M. (2000). Emergence ofganciclovir-resistant cytomegalovirus disease among recipi ents ofsolid-organ transplants. Lancet, 356, 645-649.
6.
Male, D. (1991). Immune recognition. In Immunology: An illustrated outline (pp. 21-46). London: Gower Medical.
7.
Meier-Kriesche, H. , Port, F. K., Ojo, A. O., Rudich, S. M., Hanson, J. A., Cibrik, D. M., et al. (2000). Effect of waiting time on renal transplant outcome. Kidney International, 58, 1311-1317.
8.
Morris, P. M. (1999). Renal transplantation. In L. C. Ginns, A. B. Cosimi, & P. J. Morris (Eds.), Transplantation (pp. 285-311). Malden, MA: Blackwell Science.
9.
Nogueira, J. M. , Cangro, C. B., Fink, J. C., Schweitzer, E., Wiland, A., Klassen, D. K., et al. (1999). A comparison ofrecipient renal outcomes with laparoscopic versus open live donor nephrectomy. Transplantation, 67, 722-728.
10.
Pescovitz, M. D. , Rabkin, J., Merion, R. M., Paya, C. V., Pirsch, J., Freeman, R. B., et al. (2000). Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients. Antimicrobial Agents and Chemotherapy, 44, 2811-2815.
11.
Pirsch, J. , Simmons, W. D., & Sollinger, H. (1999). Transplantation drug manual. Austin, TX: Landes Bioscience.
12.
Rubin, R. H. (1993). Infectious disease complications of renal transplantation. Kidney International, 44, 221-236.
13.
Schlatter, S. , & McNatt, G. E. (1995). Risk ofcommunity infections in transplant patients: A literature review. ANNA Journal, 22, 590-595, 630-630.
14.
Steinman, T. I. , Becker, B. N., Frost, A. E., Olthoff, K. M., Smart, F. W., Suki, W. N., et al. (2001). Guidelines for the referral and management of patients eligible for solid organ transplantation. Transplantation, 71, 1189-1204.
15.
Tanphaichitr, N. T. , & Brennan, D. C. (2000). Infectious complications in renal transplant recipients. Advances in Renal Replacement Therapy, 7, 131-146.
16.
Wolfe, R. A. , Ashby, V. B., Milford, E. L., Ojo, A. O., Ettenger, R. E., Agodoa, L.Y.C., et al. (1999). Comparison ofmortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients ofa first cadaveric transplant. New England Journal of Medicine, 34, 1725-1730.
